New Search
If you are not happy with the results below please do another search
9 search results for: neuroprotection
Cannabis, Herbs & the Mind/Body Connection
/in Misc, NewsJames Brent, DDS outlines the mind/body connection and how cannabis and other herbs may help bring the gut and the brain into alignment.
Cultivating a Deeper Relationship with Cannabis Medicine
/in Misc, NewsJames Brent, DDS explores the deeper connection healthcare professionals can have with the cannabis plant inspired from the herbalist perspective.
Cannflavins – From plant to patient: A scoping review
/in MiscAuthors: Simon Erridge, Nagina Mangal, Oliver Salazar, Barbara Pacchetti, Mikael H.Sodergren Published in Fitoterapia October 2020 Abstract Introduction Cannflavins are a group of prenylflavonoids derived from Cannabis sativa L.. Cannflavin A (CFL-A), B (CFL-B) and C (CFL-C) have been heralded for their anti-inflammatory properties in pre-clinical evaluations. This scoping review aims to synthesise the evidence…
Cannabis Therapeutics and the Future of Neurology
/in Cancer, Misc, Multiple Sclerosis, Neuroprotection, Tourette's SyndromeAuthor: Ethan B. Russo Published in: Frontiers in Integrative Neuroscience October 2018 Abstract Introduction: Cannabis burst across the Western medicine horizon after its introduction by William O’Shaughnessy in 1838 (O’Shaughnessy, 1838–1840; Russo, 2017b), who described remarkable successes in treating epilepsy, rheumatic pains, and even universally fatal tetanus with the “new” drug. Cannabis, or “Indian hemp,” was…
IACM 2019 Highlights: Defending Doctors’ Rights Across the Globe
/in NewsThe IACM conference in Berlin highlighted talks from the top professionals in the field of cannabis science. Christine Milentis, our Executive Secretary, reports on the history of cannabis for medical use and the rights of doctors across the globe to prescribe it.
Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia.
/in Cerebral palsy, NeuroprotectionAuthors: A.L. Solevåga, G.M. Schmölzer, P.-Y.Cheung
Free Radical Biology and Medicine, October 2019
—
Perinatal asphyxia-induced brain injury may present as hypoxic-ischemic encephalopathy in the neonatal period, and disability including cerebral palsy in the long term. The brain injury is secondary to both the hypoxic-ischemic event and the reoxygenation-reperfusion following…
The dual neuroprotective-neurotoxic profile of cannabinoid drugs.
/in NeuroprotectionAuthors: Yosef Sarne, Fadi Asaf, Miriam Fishbein, Mikhal Gafni, Ora Keren
British Journal of Pharmacology, August 2011
—
Extensive in vitro and in vivo studies have shown that cannabinoid drugs have neuroprotective properties and suggested that the endocannabinoid system may be involved in endogenous neuroprotective mechanisms. On the other hand, neurotoxic effects of cannabinoids in vitro and i…
Role of cannabinoids in multiple sclerosis.
/in Autoimmune Disease, Multiple SclerosisAuthors: John P. Zajicek, Vicentiu I. Apostu
CNS Drugs, March 2011
—
Although extracts from the cannabis plant have been used medicinally for thousands of years, it is only within the last 2 decades that our understanding of cannabinoid physiology and the provision of evidence for therapeutic benefit of cannabinoids has begun to accumulate. Thi…
Our Mission
The SCC provides continuing education for ourselves, patients, and colleagues about the medical use of cannabis and best practices in clinical care.
BECOME A MEMBER
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.